Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma

Bhavi Patel, Hnin Khine, Ami Shah, Deborah Sung, Shivanand Medar, Lewis Singer

Research output: Contribution to journalArticle

Abstract

Objective: To compare the effects of high concentration to titrated oxygen therapy (HCOT) on transcutaneous carbon dioxide (PtCO2) level in pediatric asthma exacerbation. Titrated oxygen therapy (TOT) in acute asthma will avoid a rise in PtCO 2 in the pediatric population. Method: The study design is a prospective, randomized, clinical trial comparing HCOT (maintain SpO2 92-95%) while being treated for asthma exacerbation in the emergency department (ED). Inclusion criteria: 2 to 18 years, previously diagnosed asthma with acute exacerbation (asthma score >5). PtCO2 and asthma scores were measured at 0, 20, 40, 60 minutes and then every 30 minutes until disposition decision. The primary outcome was a change in PtCO 2. Secondary outcomes were admission rate and change in asthma score. Results: A total of 96 patients were enrolled in the study with a mean age of 8.27 years; 49 in HCOT and 47 in the TOT group. The 0 minute PtCO2 was similar (35.33 + 3.88 HCOT vs 36.66 + 4.69 TOT, P = 0.13); whereas, the 60 minutes PtCO 2 was higher in the HCOT (38.08 + 5.11 HCOT vs 35.51 + 4.57 TOT, P = 0.01). The asthma score was similar at 0 minute (7.55 + 1.34 HCOT vs 7.30 + 1.18 TOT, P = 0.33); whereas, the 60 minutes asthma score was lower in the TOT (4.71 + 1.38 HCOT vs 3.57 + 1.25 TOT, P = 0.0001). The rate of admission to the hospital was 40.5% in HCOT vs 25.5% in the TOT (P = 0.088). Conclusions: HCOT in pediatric asthma exacerbation leads to significantly higher carbon dioxide levels, which increases asthma scores and trends towards the increasing rate of admission. Larger studies are needed to explore this association.

Original languageEnglish (US)
Pages (from-to)970-976
Number of pages7
JournalPediatric pulmonology
Volume54
Issue number7
DOIs
StatePublished - Jul 1 2019
Externally publishedYes

Fingerprint

Asthma
Randomized Controlled Trials
Pediatrics
Oxygen
Therapeutics
Carbon Dioxide
Group Psychotherapy

Keywords

  • asthma
  • oxygen
  • pediatric asthma exacerbation
  • transcutaneous carbon dioxide (PtCO)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma. / Patel, Bhavi; Khine, Hnin; Shah, Ami; Sung, Deborah; Medar, Shivanand; Singer, Lewis.

In: Pediatric pulmonology, Vol. 54, No. 7, 01.07.2019, p. 970-976.

Research output: Contribution to journalArticle

Patel, Bhavi ; Khine, Hnin ; Shah, Ami ; Sung, Deborah ; Medar, Shivanand ; Singer, Lewis. / Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma. In: Pediatric pulmonology. 2019 ; Vol. 54, No. 7. pp. 970-976.
@article{d7de485cc27a403d81680328d3793234,
title = "Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma",
abstract = "Objective: To compare the effects of high concentration to titrated oxygen therapy (HCOT) on transcutaneous carbon dioxide (PtCO2) level in pediatric asthma exacerbation. Titrated oxygen therapy (TOT) in acute asthma will avoid a rise in PtCO 2 in the pediatric population. Method: The study design is a prospective, randomized, clinical trial comparing HCOT (maintain SpO2 92-95{\%}) while being treated for asthma exacerbation in the emergency department (ED). Inclusion criteria: 2 to 18 years, previously diagnosed asthma with acute exacerbation (asthma score >5). PtCO2 and asthma scores were measured at 0, 20, 40, 60 minutes and then every 30 minutes until disposition decision. The primary outcome was a change in PtCO 2. Secondary outcomes were admission rate and change in asthma score. Results: A total of 96 patients were enrolled in the study with a mean age of 8.27 years; 49 in HCOT and 47 in the TOT group. The 0 minute PtCO2 was similar (35.33 + 3.88 HCOT vs 36.66 + 4.69 TOT, P = 0.13); whereas, the 60 minutes PtCO 2 was higher in the HCOT (38.08 + 5.11 HCOT vs 35.51 + 4.57 TOT, P = 0.01). The asthma score was similar at 0 minute (7.55 + 1.34 HCOT vs 7.30 + 1.18 TOT, P = 0.33); whereas, the 60 minutes asthma score was lower in the TOT (4.71 + 1.38 HCOT vs 3.57 + 1.25 TOT, P = 0.0001). The rate of admission to the hospital was 40.5{\%} in HCOT vs 25.5{\%} in the TOT (P = 0.088). Conclusions: HCOT in pediatric asthma exacerbation leads to significantly higher carbon dioxide levels, which increases asthma scores and trends towards the increasing rate of admission. Larger studies are needed to explore this association.",
keywords = "asthma, oxygen, pediatric asthma exacerbation, transcutaneous carbon dioxide (PtCO)",
author = "Bhavi Patel and Hnin Khine and Ami Shah and Deborah Sung and Shivanand Medar and Lewis Singer",
year = "2019",
month = "7",
day = "1",
doi = "10.1002/ppul.24329",
language = "English (US)",
volume = "54",
pages = "970--976",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Randomized clinical trial of high concentration versus titrated oxygen use in pediatric asthma

AU - Patel, Bhavi

AU - Khine, Hnin

AU - Shah, Ami

AU - Sung, Deborah

AU - Medar, Shivanand

AU - Singer, Lewis

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Objective: To compare the effects of high concentration to titrated oxygen therapy (HCOT) on transcutaneous carbon dioxide (PtCO2) level in pediatric asthma exacerbation. Titrated oxygen therapy (TOT) in acute asthma will avoid a rise in PtCO 2 in the pediatric population. Method: The study design is a prospective, randomized, clinical trial comparing HCOT (maintain SpO2 92-95%) while being treated for asthma exacerbation in the emergency department (ED). Inclusion criteria: 2 to 18 years, previously diagnosed asthma with acute exacerbation (asthma score >5). PtCO2 and asthma scores were measured at 0, 20, 40, 60 minutes and then every 30 minutes until disposition decision. The primary outcome was a change in PtCO 2. Secondary outcomes were admission rate and change in asthma score. Results: A total of 96 patients were enrolled in the study with a mean age of 8.27 years; 49 in HCOT and 47 in the TOT group. The 0 minute PtCO2 was similar (35.33 + 3.88 HCOT vs 36.66 + 4.69 TOT, P = 0.13); whereas, the 60 minutes PtCO 2 was higher in the HCOT (38.08 + 5.11 HCOT vs 35.51 + 4.57 TOT, P = 0.01). The asthma score was similar at 0 minute (7.55 + 1.34 HCOT vs 7.30 + 1.18 TOT, P = 0.33); whereas, the 60 minutes asthma score was lower in the TOT (4.71 + 1.38 HCOT vs 3.57 + 1.25 TOT, P = 0.0001). The rate of admission to the hospital was 40.5% in HCOT vs 25.5% in the TOT (P = 0.088). Conclusions: HCOT in pediatric asthma exacerbation leads to significantly higher carbon dioxide levels, which increases asthma scores and trends towards the increasing rate of admission. Larger studies are needed to explore this association.

AB - Objective: To compare the effects of high concentration to titrated oxygen therapy (HCOT) on transcutaneous carbon dioxide (PtCO2) level in pediatric asthma exacerbation. Titrated oxygen therapy (TOT) in acute asthma will avoid a rise in PtCO 2 in the pediatric population. Method: The study design is a prospective, randomized, clinical trial comparing HCOT (maintain SpO2 92-95%) while being treated for asthma exacerbation in the emergency department (ED). Inclusion criteria: 2 to 18 years, previously diagnosed asthma with acute exacerbation (asthma score >5). PtCO2 and asthma scores were measured at 0, 20, 40, 60 minutes and then every 30 minutes until disposition decision. The primary outcome was a change in PtCO 2. Secondary outcomes were admission rate and change in asthma score. Results: A total of 96 patients were enrolled in the study with a mean age of 8.27 years; 49 in HCOT and 47 in the TOT group. The 0 minute PtCO2 was similar (35.33 + 3.88 HCOT vs 36.66 + 4.69 TOT, P = 0.13); whereas, the 60 minutes PtCO 2 was higher in the HCOT (38.08 + 5.11 HCOT vs 35.51 + 4.57 TOT, P = 0.01). The asthma score was similar at 0 minute (7.55 + 1.34 HCOT vs 7.30 + 1.18 TOT, P = 0.33); whereas, the 60 minutes asthma score was lower in the TOT (4.71 + 1.38 HCOT vs 3.57 + 1.25 TOT, P = 0.0001). The rate of admission to the hospital was 40.5% in HCOT vs 25.5% in the TOT (P = 0.088). Conclusions: HCOT in pediatric asthma exacerbation leads to significantly higher carbon dioxide levels, which increases asthma scores and trends towards the increasing rate of admission. Larger studies are needed to explore this association.

KW - asthma

KW - oxygen

KW - pediatric asthma exacerbation

KW - transcutaneous carbon dioxide (PtCO)

UR - http://www.scopus.com/inward/record.url?scp=85067787186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067787186&partnerID=8YFLogxK

U2 - 10.1002/ppul.24329

DO - 10.1002/ppul.24329

M3 - Article

C2 - 30945478

AN - SCOPUS:85067787186

VL - 54

SP - 970

EP - 976

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 7

ER -